Peptide Therapeutics Market (By Application: Gastrointestinal Disorder, Metabolic Disorder, Neurological Disorder, Cancer; By Type: Generic, Innovative; By Route of Administration: Oral, Parenteral, Pulmonary, Mucosal; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Drug Stores; By Synthesis Technology: Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Peptide Therapeutics Market, by Application, 2023-2032
8.1.1. Gastrointestinal Disorder
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Metabolic Disorder
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Neurological Disorder
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cancer
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
9.1. Peptide Therapeutics Market, by Type, 2023-2032
9.1.1. Generic
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Innovative
9.1.2.1. Market Revenue and Forecast (2020-2032)
10.1. Peptide Therapeutics Market, by Route of Administration, 2023-2032
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Pulmonary
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Mucosal
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
11.1. Peptide Therapeutics Market, by Distribution Channel, 2023-2032
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Online Drug Stores
11.1.3.1. Market Revenue and Forecast (2020-2032)
12.1. Peptide Therapeutics Market, by Synthesis Technology, 2023-2032
12.1.1. Solid Phase peptide Synthesis (SPPS)
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Liquid Phase Peptide Synthesis (LPPS)
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Hybrid Technology
12.1.3.1. Market Revenue and Forecast (2020-2032)
13.1. North America
13.1.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.6.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.7.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.7. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.8. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.10. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.11. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.13. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.15. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
14.1. Eli Lilly & Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Amgen Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Pfizer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ever Neuro Pharma GmbH
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bausch Health
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbvie
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample